Sequential 5-Aza 2′-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells
暂无分享,去创建一个
D. Beer | Julie A Hong | D. Schrump | J. Trepel | D. Nguyen | G. Chen | Z. Guo | Sunmin Lee | T. Weiser | E. Kassis | Federico A Steiner | M. Fischette | Maria R. Fischette
[1] U. Pendurthi,et al. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. , 2004, Blood.
[2] W. Kisiel,et al. The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice. , 2004, Blood.
[3] G. Nicolson,et al. In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2 , 2004, Clinical & Experimental Metastasis.
[4] G. Nicolson,et al. Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion , 2004, Clinical & Experimental Metastasis.
[5] M. Szyf,et al. Valproate Induces Replication-independent Active DNA Demethylation* , 2003, Journal of Biological Chemistry.
[6] K. Srivenugopal,et al. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), in human glioma cells , 2003, Oncogene.
[7] M. Whiteway,et al. The ERK/MAPK Pathway Regulates the Activity of the Human Tissue Factor Pathway Inhibitor-2 Promoter* , 2003, The Journal of Biological Chemistry.
[8] Peter A. Jones,et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment. , 2002, Blood.
[9] Gillian Murphy,et al. Metalloproteinase inhibitors: biological actions and therapeutic opportunities , 2002, Journal of Cell Science.
[10] J. Minna,et al. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14ARF, p16INK4a and RASSF1A in human lung cancer cell lines , 2002, Oncogene.
[11] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[12] L. Neckers,et al. Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. , 2002, Journal of the National Cancer Institute.
[13] R. Hruban,et al. Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived , 2002, Oncogene.
[14] G. Kouraklis,et al. Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas , 2002, Oncogene.
[15] Vigushin Dm,et al. Histone deacetylase inhibitors in cancer treatment. , 2002 .
[16] G. Bae,et al. Activation of p21WAF1/Cip1 Transcription through Sp1 Sites by Histone Deacetylase Inhibitor Apicidin , 2001, The Journal of Biological Chemistry.
[17] M. Szyf,et al. Demethylase Activity Is Directed by Histone Acetylation* , 2001, The Journal of Biological Chemistry.
[18] C. N. Rao,et al. A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion , 2001, Oncogene.
[19] P. Parsons,et al. Histone Hyperacetylation Induced by Histone Deacetylase Inhibitors Is Not Sufficient to Cause Growth Inhibition in Human Dermal Fibroblasts* , 2001, The Journal of Biological Chemistry.
[20] Keith D Robertson,et al. DNA methylation, methyltransferases, and cancer , 2001, Oncogene.
[21] P. Libby,et al. Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. , 2001, The Journal of clinical investigation.
[22] F. Marincola,et al. Sequential 5-Aza-2′-deoxycytidine-Depsipeptide FR901228 Treatment Induces Apoptosis Preferentially in Cancer Cells and Facilitates Their Recognition by Cytolytic T Lymphocytes Specific for NY-ESO-1 , 2001, Journal of immunotherapy.
[23] Julie A Hong,et al. Induction of MAGE-3 expression in lung and esophageal cancer cells. , 2001, The Annals of thoracic surgery.
[24] P. Marks,et al. Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] C. Heldin,et al. Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB-stimulated chemotaxis. , 2000, Blood.
[26] W. Kisiel,et al. Paradoxical Pro-invasive Effect of the Serine Proteinase Inhibitor Tissue Factor Pathway Inhibitor-2 on Human Hepatocellular Carcinoma Cells* , 2000, The Journal of Biological Chemistry.
[27] M. Yoshida,et al. Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells. , 2000, The Journal of antibiotics.
[28] C. N. Rao,et al. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2. , 2000, Biochemical and biophysical research communications.
[29] J. Stam,et al. Factor VIIa/Tissue Factor-induced Signaling via Activation of Src-like Kinases, Phosphatidylinositol 3-Kinase, and Rac* , 2000, The Journal of Biological Chemistry.
[30] P. Marks,et al. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[31] E. Sausville,et al. P21-dependent G 1 arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228 , 2000, British Journal of Cancer.
[32] C. Ponting,et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases , 2000, Nature.
[33] P. Marks,et al. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. , 2000, Journal of the National Cancer Institute.
[34] W. Kisiel,et al. Nucleotide Sequence of the Gene Encoding Murine Tissue Factor Pathway Inhibitor-2 , 2000, Thrombosis and Haemostasis.
[35] C. N. Rao,et al. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin. , 1999, Archives of biochemistry and biophysics.
[36] P. Nawroth,et al. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Sasayama,et al. Tissue Factor Pathway Inhibitor-2 Is a Novel Mitogen for Vascular Smooth Muscle Cells* , 1999, The Journal of Biological Chemistry.
[38] C. N. Rao,et al. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor. , 1999, Biochemical and biophysical research communications.
[39] M. Yoshida,et al. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. , 1998, Experimental cell research.
[40] W. Ruf,et al. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. , 1998, The Journal of clinical investigation.
[41] L. Poulsen,et al. Signal Transduction via the Mitogen-activated Protein Kinase Pathway Induced by Binding of Coagulation Factor VIIa to Tissue Factor* , 1998, The Journal of Biological Chemistry.
[42] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[43] R. Jaenisch,et al. Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] W. Kisiel,et al. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[45] T S Edgington,et al. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[46] W. Kisiel,et al. Occurrence of blood coagulation factors in situ in small cell carcinoma of the lung , 1987, Cancer.